Activation of hypoxia-inducible factor-1 via nuclear factor-B in rats with chronic obstructive pulmonary disease

Acta Biochimica et Biophysica Sinica

Volumn 42, Issue 7, 2010, Pages 483-488

  Jiang, Hong ^a   Zhu, Yesen ^a   Xu, Hui ^a   Sun, Yu ^a   Li, Qifang ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

chronic obstructive pulmonary disease; hypoxia; inflammation; nuclear factor B

Indexed keywords

ANTIOXIDANT; CYTOKINE; HEME OXYGENASE 1; HYPOXIA INDUCIBLE FACTOR 1ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; PYRROLIDINE DERIVATIVE; PYRROLIDINE DITHIOCARBAMIC ACID; THIOCARBAMIC ACID DERIVATIVE; VASCULOTROPIN A;

ANIMAL; ARTICLE; BLOOD GAS ANALYSIS; CHEMISTRY; CHRONIC OBSTRUCTIVE LUNG DISEASE; DRUG ANTAGONISM; DRUG EFFECT; GENETICS; IMMUNOBLOTTING; LUNG; LUNG FUNCTION TEST; LUNG LAVAGE; MALE; METABOLISM; ORAL DRUG ADMINISTRATION; PATHOPHYSIOLOGY; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SMOKE; SPRAGUE DAWLEY RAT; TOBACCO;

ADMINISTRATION, ORAL; ANIMALS; ANTIOXIDANTS; BLOOD GAS ANALYSIS; BRONCHOALVEOLAR LAVAGE FLUID; CYTOKINES; HEME OXYGENASE-1; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; IMMUNOBLOTTING; LIPOPOLYSACCHARIDES; LUNG; MALE; NF-KAPPA B; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; PYRROLIDINES; RATS; RATS, SPRAGUE-DAWLEY; RESPIRATORY FUNCTION TESTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SMOKE; THIOCARBAMATES; TOBACCO; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

RATTUS;

EID: 77954422157     PISSN: 16729145     EISSN: 17457270     Source Type: Journal    
DOI: 10.1093/abbs/gmq041     Document Type: Article

References (30)

1. Baldwin AS, Jr. Series introduction: the transcription factor NF-kappaB and human disease. J Clin Invest 2001, 107: 3-6.
2. Di Stefano A, Caramori G, Oates T, Capelli A, Lusuardi M, Gnemmi I and Ioli F, et al. Increased expression of nuclear factor-kappaB in bronchial biopsies from smokers and patients with COPD. Eur Respir J 2002, 20: 556-563.
3. Edwards MR, Bartlett NW, Clarke D, Birrell M, Belvisi M and Johnston SL. Targeting the NF-kappaB pathway in asthma and chronic obstructive pulmonary disease. Pharmacol Ther 2009, 121: 1-13.
4. Taylor CT. Interdependent roles for hypoxia inducible factor and nuclear factor-kappaB in hypoxic inflammation. J Physiol 2008, 586: 4055-4059.
5. Huang LE, Gu J, Schau M and Bunn HF. Regulation of hypoxia-inducible factor 1alpha is mediated by an O2-dependent degradation domain via the ubiquitin-proteasome pathway. Proc Natl Acad Sci USA 1998, 95: 7987-7992.
6. Hellwig-Burgel T, Rutkowski K, Metzen E, Fandrey J and Jelkmann W. Interleukin-1beta and tumor necrosis factor-alpha stimulate DNA binding of hypoxia-inducible factor-1. Blood 1999, 94: 1561-1567.
7. Scharte M, Han X, Bertges DJ, Fink MP and Delude RL. Cytokines induce HIF-1 DNA binding and the expression of HIF-1-dependent genes in cultured rat enterocytes. Am J Physiol Gastrointest Liver Physiol 2003, 284: 373-384.
8. Li QF and Dai AG. Hypoxia inducible factor-1 alpha correlates the expression of heme oxygenase 1 gene in pulmonary arteries of rat with hypoxia-induced pulmonary hypertension. Acta Biochim Biophys Sin 2004, 36: 133-140.
9. Tamada S, Nakatani T, Asai T, Tashiro K, Komiya T, Sumi T and Okamura M, et al. Inhibition of nuclear factor-kappaB activation by pyrrolidine dithiocarbamate prevents chronic FK506 nephropathy. Kidney Int 2003, 63: 306-314.
10. Miller LM, Foster WM, Dambach DM, Doebler D, McKinnon M, Killar L and Longphre M. A murine model of cigarette smoke-induced pulmonary inflammation using intranasally administered smoke-conditioned medium. Exp Lung Res 2002, 28: 435-455.
11. Xu L, Cai BQ and Zhu YJ. Pathogenesis of cigarette smoke-induced chronic obstructive pulmonary disease and therapeutic effects of glucocorticoids and N-acetylcysteine in rats. Chin Med J 2004, 117: 1611-1619.
12. Ju CR, Xia XZ and Chen RC. Expressions of tumor necrosis factorconverting enzyme and ErbB3 in rats with chronic obstructive pulmonary disease. Chin Med J 2007, 120: 1505-1510.
13. Heidbreder M, Fröhlich F, Jöhren O, Dendorfer A, Qadri F and Dominiak P. Hypoxia rapidly activates HIF-3alpha mRNA expression. FASEB J 2003, 17: 1541-1543.
14. Li QF, Wang XR, Yang YW and Lin H. Hypoxia upregulates hypoxia inducible factor (HIF)-3alpha expression in lung epithelial cells: characterization and comparison with HIF-1alpha. Cell Res 2006, 16: 548-558.
15. Semenza GL. Pulmonary vascular responses to chronic hypoxia mediated by hypoxia-inducible factor 1. Proc Am Thorac Soc 2005, 2: 68-70.
16. Shinohara T, Kaneko T, Nagashima Y, Ueda A, Tagawa A and Ishigatsubo Y. Adenovirus-mediated transfer and overexpression of heme oxygenase 1 cDNA in lungs attenuates elastase-induced pulmonary emphysema in mice. Hum Gene Ther 2005, 16: 318-327.
17. Stevenson CS, Coote K, Webster R, Johnston H, Atherton HC, Nicholls A and Giddings J, et al. Characterization of cigarette smoke-induced inflammatory and mucus hypersecretory changes in rat lung and the role of CXCR2 ligands in mediating this effect. Am J Physiol Lung Cell Mol Physiol 2005, 288: 514-522.
18. Chen F, Castranova V, Shi X and Demers LM. New insights into the role of nuclear factor-kappaB, a ubiquitous transcription factor in the initiation of diseases. Clin Chem 1999, 45: 7-17.
19. Yu AY, Frid MG, Shimoda LA, Wiener CM, Stenmark K and Semenza GL. Temporal, spatial, and oxygen-regulated expression of hypoxia-inducible factor-1 in the lung. Am J Physiol 1998, 275: 818-826.
20. Li QF and Dai AG. Hypoxia-inducible factor-1alpha regulates the role of vascular endothelial growth factor on pulmonary arteries of rats with hypoxia-induced pulmonary hypertension. Chin Med J 2004, 117: 1023-1028.
21. Kranenburg AR, De Boer WI, Alagappan VK, Sterk PJ and Sharma HS. Enhanced bronchial expression of vascular endothelial growth factor and receptors (Flk-1 and Flt-1) in patients with chronic obstructive pulmonary disease. Thorax 2005, 60: 106-113.
22. Kasahara Y, Tuder RM, Taraseviciene-Stewart L, Le Cras TD, Abman S, Hirth PK and Waltenberger J, et al. Inhibition of VEGF receptors causes lung cell apoptosis and emphysema. J Clin Invest 2000, 106: 1311-1319.
23. Michaud SE, Menard C, Guy LG, Gennaro G and Rivard A. Inhibition of hypoxia-induced angiogenesis by cigarette smoke exposure: impairment of the HIF-1alpha/VEGF pathway. FASEB J 2003, 17: 1150-1152.
24. Peinado VI, Barberá JA, Abate P, Raḿrez J, Roca J, Santos S and Rodriguez-Roisin R. Inflammatory reaction in pulmonary muscular arteries of patients with mild chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999, 159: 1605-1611.
25. Siafakas NM, Antoniou KM and Tzortzaki EG. Role of angiogenesis and vascular remodeling in chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis 2007, 2: 453-462.
26. Iyer NV, Kotch LE, Agani F, Leung SW, Laughner E, Wenger RH and Gassmann M, et al. Cellular and developmental control of O2 homeostasis by hypoxia-inducible factor-1alpha. Genes Dev 1998, 12: 149-162.
27. Foresti R and Motterlini R. The heme oxygenase pathway and its interaction with nitric oxide in the control of cellular homeostasis. Free Radic Res 1999, 31: 459-475.
28. Willis D, Moore AR, Frederick R and Willoughby DA. Heme oxygenase: a novel target for the modulation of the inflammatory response. Nat Med 1996, 2: 87-90.
29. Poss KD and Tonegawa S. Heme oxygenase 1 is required for mammalian iron reutilization. Proc Natl Acad Sci USA 1997, 94: 10919-10924.
30. Yachie A, Niida Y, Wada T, Igarashi N, Kaneda H, Toma T and Ohta K, et al. Oxidative stress causes enhanced endothelial cell injury in human heme oxygenase-1 deficiency. J Clin Invest 1999, 103: 129-135.